Androgens, Dihydrotestosterone (DHT), and testosterone bind with the ligand binding domain of the androgen receptor (AR) and stimulate the growth of prostate cancer (Ferlay et al., 2010; Elancheran et al., 2015). The gene discussed is AR; the disease is prostate cancer.